lobbying_activities: 989140

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
989140	ef35269b-19b7-482c-a8ce-0d0e1878ab00	Q3	PARRY, ROMANI, DECONCINI & SYMMS	30792	MEDICIS PHARMACEUTICAL CORPORATION	2010	third_quarter	CPT	H.R. 1706 and S. 369, Oppose bills that prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. Oppose legislation that prohibits settlement agreements between patent litigants that involve anything of value.	SENATE	15000		0	0	2010-10-08T14:40:03.413000-04:00